Nordic consensus report on asthma management

Respiratory Medicine

Volumn 94, Issue 4, 2000, Pages 299-327

  Dahl, Ronald ^a   Bjermer, Leif ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; ANTIBIOTIC AGENT; BECLOMETASONE DIPROPIONATE; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; CROMOGLYCATE DISODIUM; HYDROCORTISONE; HYDROCORTISONE SODIUM SUCCINATE; IPRATROPIUM BROMIDE; LEUKOTRIENE RECEPTOR BLOCKING AGENT; METHYLPREDNISOLONE; METHYLPREDNISOLONE SODIUM SUCCINATE; NEDOCROMIL; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISOLONE; PREDNISONE; SALBUTAMOL; STEROID; TERBUTALINE; THEOPHYLLINE;

ASTHMA; DENMARK; EUROPE; FINLAND; HUMAN; ICELAND; IMMUNOLOGY; LUNG; MEDICAL RESEARCH; NORWAY; PEDIATRICIAN; PHYSICIAN; PRIORITY JOURNAL; REVIEW; SOCIOECONOMICS; SWEDEN;

EID: 0034117719     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1053/rmed.1999.0702     Document Type: Article

References (158)

1. Rönmark E, Lundbäck B, Jönsson E, Jonsson A C, Lindstrom M, Sandstrom T. Incidence of asthma in adults-report from the Obstructive Lung Disease in Northern Sweden Study. Allergy. 52:1997;1071-1078.
2. Larsson L, Boethius G. Differences in utilization of asthma drugs between two neighbouring Swedish provinces: relation to treatment in individuals with airway disease. J Intern Med. 238:1995;307-316.
3. Carlsen K-H. Epidemiology of childhood asthma. Eur Respir Rev. 4:1994;5-9.
4. Åberg N, Engström I, Lindberg U. Allergic diseases in Swedish school children. Acta Paediatr Scand. 78:1989;246-252.
5. Nystad W, Magnus P, Guslvik A. Increasing risk of asthma without other atopic diseases in school children, a repeated cross-sectional study after 13 years. Eur J Epidemiol. 14:1998;247-252.
6. Taylor W-R, Newacheck P-W. Impact of childhood asthma on health. Pediatrics. 90:1992;657-662.
7. Sly R M. Changing prevalence of allergic rhinitis and asthma. Ann Allergy Asthma Immunol. 82:1999;233-252.
8. Weiss K B, Gergen P J, Wagener D K. Breathing better or wheezing worse? The changing epidemiology of asthma morbidity and mortality. Annu Rev Public Health. 90:1991;939-944.
9. Wennergren G, Kristjansson S, Strannegård I-L. Decreased hospitalization for childhood asthma with increased use of anti-inflammatory treatment, despite a rising asthma prevalence. J Allergy Clin Immunol. 93:1994;259.
10. Gerdtham, U-G, Hertzman, P, Boman, G, Jönsson, B, Impact of inhaled corticosteriods on asthma hospitalization in Sweden: a pooled regression analysis, EFI research report Centre for Health Economies, Stockholm, 1993.
11. Haahtela T, Klaukka T. Societal and health care benefits of early use of inhaled steroids. Thorax. 53:1998;1005-1006.
12. Åberg N, Engström I. Natural history of allergic diseases in children. Acta Paediatr Scand. 79:1990;206-211.
13. Nystad W, Magnus P, Gulsvik A, Skarpaas I J, Carlsen K H. Changing prevalence of asthma in school children: evidence for diagnostic changes in asthma in two surveys 13 years apart. Eur Respir J. 10:1997;1046-1051.
14. Wahn U, Lau S, Bergmann R. Indoor allergen exposure is a risk factor for sensitisation during the first three years of life. J Allergy Clin Immunol. 99:1997;763-769.
15. Sporik R, Holgate S T, Platts-Mills T AE, Cogswell J J. Exposure to house dust mite allergen (Der p 1) and the development of asthma in childhood: A prospective study. N Engl J Med. 323:1990;502-507.
16. Strachan D P, Coch D G. Parental smoking and childhood asthma; longitudinal and case-controlled studies. Thorax. 53:1998;204-212.
17. Paggiaro P L, Vagaggini B, Bacci E, Bancalari L, Carrara M, Di Franco A. Prognosis of occupational asthma. Eur Respir J. 7:4:1994;761-768.
18. Lödrup Carlsen K C, Stenzler A, Carlsen K H. Determinants of tidal flow volume loop indices in neonates and children with and without asthma. Pediatr Pulmonol. 24:1997;391-396.
19. Chanez P, Vignola A M, O'Shaugnessy T, Enander I, Li D, Jeffery P K. Corticosteroid reversibility in COPD is related to features of asthma. Am J Respir Crit Care Med. 155:1997;1529-1534.
20. Foucard T. The wheezy child. Acta Paediatr Scand. 74:1985;172-178.
21. Skoner D, Caliguiri L. The wheezing infant. Pediatr Clin North Am. 35:1988;1011-1030.
22. Busse W W. Respiratory infections: their role in airway responsiveness and the pathogenesis of asthma. J Allergy Clin Immunol. 85:1990;671-688.
23. Wennergren G, Hansson S, Engström I, Jodal U, Åmark M, Brolin I. Characteristics and prognosis of hospital-treated obstructive bronchitis in children aged less than two years. Acta Paediatr. 81:1992;40-45.
24. Mok J YQ, Simpson H. Outcome for acute bronchitis, bronchiolitis and pneumonia in infancy. Arch Dis Child. 59:1984;306-309.
25. Wennergren G, Åmark M, Åmark K, Oskarsdottir S, Sten G, Redfors S. Wheezing bronchitis reinvestigated at the age of 10 years. Acta Paediatr. 86:1997;351-355.
26. Eiriksson T H, Sigurgeirsson B, Ardal B, Sigfusson A, Valdimarsson H. Cord Blood IgE levels are influenced by gestational age but do not predict allergic manifestations in infants. Pediatr Allergy Immunol. 5:1994;5-10.
27. Reijonen T M, Korppi M. One-year follow-up of young children hospitalized for wheezing: the influence of early anti-inflammatory therapy and risk factors for subsequent wheezing and asthma. Pediatr Pulmonol. 26:1998;113-119.
28. Sigurs N, Bjarnason R, Sigurbergsson F, Kjellman B, Björksten B. Asthma and immunoglobulin E antibodies after respiratory syncytial virus bronchiolitis: a prospective cohort study with matched controls. Pediatrics. 95:1995;500-505.
29. Weiss K B, Sullivan S D. The economic costs of asthma - a review and conceptual model. PharmacoEconomics. 4:1993;14-30.
30. Bryan S, Buxton M J. Economic evaluation of treatments for respiratory disease. PhamacoEconomics. 2:1992;207-218.
31. Drummond M. Cost-of-illness studies. A major headache? PhamacoEconomics. 2:1992;1-4.
32. Lenney W, Wells N EJ, O'Neill B A. The burden of paediatric asthma. Eur Respir Rev. 4:1994;49-62.
33. Mellis C M, Peat J K, Woolcock A J. The cost of asthma - can it be reduced? PhamacoEconomics. 3:1993;205-219.
34. Persson, U, Svarvar, P, Ödegaard, K, Samhällsekonomiska kostnader avseende allergiska besvär för barn/vuxna i Sverige 1983-1993, Institutet för Hälso- och sjukvårdsekonomi, Lund, 1994.
35. Lahdensuo A, Haahtela T, Herrala J. Randomised comparison of cost effectiveness of guided self management and traditional treatment of asthma in Finland. Br Med J. 316:1998;1138-1139.
36. Hide D W, Matthews S, Tariq S, Arshad S H. Allergen avoidance in infancy and allergy at 4 years of age. Allergy. 51:1996;89-93.
37. Agertoft L, Pedersen S. Effects of long-term treatment with an inhaled corticosteroid on growth and pulmonary function in asthmatic children. Respir Med. 88:1994;373-381.
38. Haahtela T, Jarvinen M, Kava T, Kiviranta K, Koskinen S, Lehtonen K. Comparison of a beta 2-agonist, terbutaline, with an inhaled corticosteroid, budesonide, in newly detected asthma. N Engl J Med. 325:1991;388-392.
39. Haahtela T, Jarvinen M, Kava T, Kiviranta K, Koskinen S, Lehtonen K. Effects of reducing or discontinuing inhaled budesonide in patients with mild asthma. N Engl J Med. 331:1994;700-705.
40. Lahdensuo A, Haahtela T, Herrala J, Kava T, Kiviranta K, Kuusisto P. Randomised comparison of cost effectiveness of guided self management and traditional treatment of asthma in Finland. Br Med J. 316:1998;1138-1139.
41. Åberg N, Sundell J, Eriksson B, Hesselmar B, Aberg B. Prevalence of allergic diseases in schoolchildren in relation to family history, upper respiratory infections, and residential characteristics. Allergy. 51:1996;232-237.
42. Donahue J G, Weiss S T, Livingston J M, Goetsch M A, Greineder D K, Platt R. Inhaled steroids and the risk of hospitalization for asthma. JAMA. 277:1997;887-891.
43. Campbell M J, Cogman G R, Holgate S, Johnston S L. Age specific trends in asthma mortality in England and Wales, 1983-1995, results of an observational study. Br Med J. 314:1997;1439-1441.
44. Nordic statistics on Medicine 1993-1995, Uppsala, Nordic council on Medicines, 1996.
45. Thorax. 52:1997;1-24.
46. Expert Panel Report II: Guidelines for the diagnosis and management of asthma. National Asthma Education and Prevention Program, National Institute of Health, Bethesda, Maryland, US, 1997.
47. Barnes G R. Delivery of patient education in asthma management. Eur Respir Rev. 8:1997;267-269.
48. Clark N M, Nothwehr F, Gong M, Ewans D, Maiman L A, Hurwity M E, Roloff D, Meloins R B. Physician-patient partnerships in managing chronic illness. Acad Med. 70:1995;957-959.
49. Becker M H. Theoretical models of adherence and strategies for improving adherence. Schumaker S A, Schron E G, Ochene J K. Handbook of Health Behaviour Change. 1990;Springer, New York.
50. The Thoracic Society of Australia and New Zealand. 1989.
51. Garrett J, Fernwick J M, Taylor G, Mitchell E, Steward J, Rea H. Prospective controlled evaluation of the effect of a community based asthma education centre in a multi racial working class neighbourhood. Thorax. 49:1994;976-983.
52. Clark N M, Gong M, Schork A, Erares D, Roloff D, Hurwity M. Impact of education for physicians on patient outcomes. Pediatrics. 101:1997;831-836.
53. Clark C R. Creating information messages for health care procedures. Patient Education and Counselling. 30:1997;247-255.
54. Meade C D, Mekiney W P, Barnes G P. Educating patients with limited literary skills: the effectiveness of printed and videotaped materials about colon cancer. Am J Public Health. 84:1994;119-121.
55. Lödrup Carlsen K C, Jaakkola J J, Nafstad P, Carlsen K H. In utero exposure to cigarette smoking influences lung function at birth. Eur Respir J. 10:1997;1774-1779.
56. Zetterström O, Osterman K, Machado L, Johansson S GO. Another smoking hazard: raised serum Ig-E concentration and increased risk of occupational allergy. Br Med J. 283:1981;1215-1217.
57. Newman L S. Occupational asthma. Clin Chest Med. 16:1995;621-636.
58. Hesselmar B, Åberg N, Åberg B, Eriksson B, Björksten B. Does early exposure to cat or dog protect against later allergy development? Clin Exp Allergy. 29:1999;611-617.
59. Braun-Fahrlander C, Gassner M, Grize L, Neu U, Seenhauser F H, Varonier H S, Vuille J C, Wutrich B. Clin Exp Allergy. 29:1999;28-34.
60. Björksten F, Suoniemi I, Koski V. Neonatal birch-pollen contact and subsequent allergy to birch pollen. Clinical allergy. 10:1980;585-591.
61. Koh Y Y, Lim H, Min K, Min Y. Airways of allergic rhinitis are primed to repeated allergen inhalation challenge. Clin Exp Allergy. 24:1994;337-346.
62. Burge S P. Occupational asthma in electronics workers caused by colophon fumes: follow up of affected workers. Thorax. 37:1982;348-353.
63. Ihre E, Zetterström O. Increase in non-specific bronchial responsiveness after repeated inhalation of low doses of allergen. Clin Exp Allergy. 23:1993;298-305.
64. Platts-Mills T A, Tovey E R, Mitchell E B, Moszoro H, Nock P, Wilkins S R. Reduction of bronchial hyperreactivity during prolonged allergen avoidance. Lancet. 2:1982;675-678.
65. van der Heide S, Kauffman H F, Dubois A E, de Monchy J G. Allergen-avoidance measures in homes of house-dust-mite-allergic asthmatic patients: effects of acaricides and mattress encasings. Allergy. 52:1997;921-927.
66. Bousquet J, Hejjaoui A, Michel F-B. Specific immunotherapy in asthma. J Allergy Clin Immunol. 86:1990;292-305.
67. Haugaard L, Dahl R, Jakobsen L. A controlled dose-response study of immunotherapy with standardized, partially purified extract of house dust mite: Clinical efficacy and side effects. J Allergy Clin Immunol. 91:1993;709-722.
68. Rak S, Löwhagen O, Venge P. The effect of immunotherapy on bronchial hyperresponsiveness and eosinophil cationic protein in pollen allergic asthma. J Allergy Clin Immunol. 82:1988;470-480.
69. Valovirta E. Capacity of specific immunotherapy in prevention of allergic asthma in children: the Preventive Allergy Treatment Study (PAT). J Invest Allergol Clin Immunol. 7:1997;369-370.
70. Johnstone D E, Dutton A. The value of hyposensitization therapy for bronchial asthma in children - a 14 year study. Pediatrics. 42:1968;793-802.
71. Bousquet J, Lockey R, Malling H J. Allergen immunotherapy: therapeutic vaccines for allergic diseases. A WHO position paper. J Allergy Clin Immunol. 102:1998;558-562.
72. Sly P, Landau L I, Weymouth H. Home recording of expiratory peak flow rate and perception of asthma. Am J Dis Child. 135:1985;479-482.
73. Clogh J B, Sly P D. Association between lower respiratory tract symptoms and fall in peak expiratory flow. Eur Respir J. 8:1995;718-722.
74. Sterk P J. Non-invasive monitoring of bronchial inflammation in asthma. Schweiz Med Wochenschr. 127:1997;1686-1692.
75. Venge P, Dahl R. Are blood eosinophil number and activity important for the development of the late asthmatic reaction after allergen challenge? Eur Respir J Suppl. 6:1989;430s-434s.
76. Venge P. The human eosinophil in inflammation. Agents Actions. 29:1990;122-126.
77. Bousquet J, Chanez P, Lacoste J Y. Indirect evidence of bronchial inflammation assessed by titration of inflammatory mediators in BAL fluid of patients with asthma. J Allergy Clin Immunol. 88:1991;649-660.
78. Ahlstedt S, Enander I, Peterson C, Rak S, Venge P. Clinical assessment of the inflammatory component of asthma with emphasis on the eosinophils. Pharm Med. 6:1992;99-111.
79. Kristjansson S, Shimizu T, Strannegård I-L, Wennergren G. Eosinophil cationic protein, myeloperoxidase and tryptase in children with asthma and atopic dermatitis. Pediatr Allergy Immunol. 5:1994;223-229.
80. Kristjansson, S, Strannegürd, I-L, Strannegård, O, Peterson, C, Enander, I, Wennergren, G, Urinary eosinophil protein X (EPX) in children with atopic asthma, J Allergy Clin Immunol.
81. Pizzichini M MM, Popov T A, Efthimiadis A, Hussack P, Evans S, Pizzichini E. Spontaneous and induced sputum to measure indices of airway inflammation in asthma. Am J Respir Crit Care Med. 154:1996;866-869.
82. Grootendorst D C, Sont J K, Willems L NA. Comparison of inflammatory cell counts in asthma: induced sputum vs bronchoalveolar lavage and bronchial biopsies. Clin Exp Allergy. 27:1997;769-779.
83. Pizzichini E, Pizzichini M MM, Efthimiadis A, Dolovich J, Hargreave F E. Measuring airway inflammation in asthma: eosinophils and eosinophilic cationic protein in induced sputum compared with peripheral blood. J Allergy Clin Immunol. 99:1997;539-544.
84. Metso T, Kilpiö K, Björkstén F, Kiviranta K, Haahtela T. Can early asthma be confirmed with laboratory tests? Allergy. 51:1996;226-231.
85. Sorva R, Metso T, Turpeinen M, Juntunen-Backman K, Björkstén F, Haahtela T. Eosinophil cationic protein in induced sputum as a marker of inflammation in asthmatic children. Pediatr Allergy Immunol. 8:1997;45-50.
86. Ulrik C S, Backer V, Dirksen A. A 10 year follow up of 180 adults with bronchial asthma: factors important for the decline in lung function. Thorax. 47:1992;14-18.
87. Hargreave F E, Ryan G, Thomson N C, O'Byrne P M, Latimer K, Juniper E F. Bronchial responsiveness to histamine or methacholine in asthma: measurement and clinical significance. J Allergy Clin Immunol. 68:1981;347-355.
88. Roorda R J, Gerritsen J, van Aalderen W M, Knol K. Influence of a positive family history and associated allergic diseases on the natural course of asthma. Clin Exp Allergy. 22:1992;627-634.
89. Waalkens H J, Van Essen-Zandvliet E EM, Gerritsen J, Duiverman E J, Kerrebijn K F, Knol K. Effects of 22 months of treatment with inhaled corticosteroids and/or beta-2-agonists on lung function, airway responsiveness, and symptoms in children with asthma. Eur Respir J. 6:1993;652-653.
90. Woolcock A J, Jenkins C R. Assessment of bronchial responsiveness as a guide to prognosis and therapy in asthma. Med Clin North Am. 74:1990;753-765.
91. Littell N T, Carlisle C C, Millman R P, Braman S S. Changes in airway resistance following nasal provocation. Am Rev Respir Dis. 141:1990;580-583.
92. Svartengren K, Philipson K, Svartengren M, Anderson M, Camner P. Tracheobronchial deposition and clearance in small airways in asthmatic subjects. Eur Respir J. 9:1996;1123-1129.
93. 2-agonist, terbutaline, on airway inflammation in newly diagnosed asthma. A randomized, double blind, paralell-group controlled trial. J Allergy Clin Immunol. 90:1992;32-42.
94. Verberne A A, Frost C, Roorda R J, van der Laag H, Kerrebijn K F. One year treatment with salmeterol compared with beclomethasone in children with asthma. The Dutch Paediatric Asthma Study Group. Am J Respir Crit Care Med. 156:1997;688-695.
95. Haahtela T, Jarvinen M, Kava T, Kiviranta K, Koskinen S, Lehtonen K. Effects of reducing or discontinuing inhaled budesonide in patients with mild asthma. N Engl J Med. 331:1994;700-705.
96. Asthma programme in Finland 1994-2004.
97. MacKenzie C. Effects of inhaled corticosteroids on growth. J Allergy Clin Immunol. 101:1998;S451-S455.
98. Ädelroth E, Inman M D, Summers E, Pace D, Modi M, O'Byrne P M. Prolonged protection against exercise-induced bronchoconstriction by the leukotrien-D4-receptor antagonist Cinalukast. J Allergy Clin Immunol. 99:1997;210-215.
99. Leff J A, Busse W W, Pearlman D, Bronsky E A, Kemp J, Hendeles L. Montelukast, a leukotriene-receptor antagonist, for the treatment of mild asthma and exercise-induced bronchoconstriction. N Engl J Med. 339:1998;147-152.
100. Dahlen B, Margolskee D J, Zetterström O, Dahlen S E. Effect of the leukotriene receptor antagonist MK-0679 on baseline pulmonary function in aspirin sensitive asthmatic subjects. Thorax. 48:1993;1205-1210.
101. Knorr B, Matz J, Bernstein J A, Nguyen H, Seidenberg B C, Reiss T F. Montelukast for chronic asthma in 6- to 14-year-old children: a randomized, double-blind trial. Pediatric Montelukast Study Group. JAMA. 279:1998;1181-1186.
102. Reiss T F, Sorkness C A, Stricker W, Botto A, Busse W W, Kundu S. Effects of montelukast (MK-0476); a potent cysteinyl leukotriene receptor antagonist, on bronchodilation in asthmatic subjects treated with and without inhaled corticosteroids. Thorax. 52:1997;45-48.
103. Pauwels R A, Löfdahl C-G, Postma D S, Tattersfield A E, OByrne P, Barnes P J. Effect of inhaled formoterol and budesonide on exacerbations of asthma. N Engl J Med. 337:1997;1405-1411.
104. Bjermer L, Larsson L. Longacting beta-2 agonists: how are they used in an optimal way? Respir Med. 91:1997;587-591.
105. Pauwels R A, Löfdahl C G, Postma D S, Tattersfield A E, O'Byrne P, Barnes P J. Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group. N Engl J Med. 337:1997;1405-1411.
106. Gross N J. Ipratropium bromide. N Engl J Med. 319:1988;486-494.
107. Simon P M, Statz E M. Drug treatment of COPD. Controversies about agents and how to deliver them. Postgrad Med. 91:1992;473-479.
108. Singh J P, Singh R, Gupta R C, Bharadwaja B. A comparative study of bronchodilator actions of ipratropium bromide (atrovent) & salbutamol (ventoline) on exercise induced bronchial asthma. J Assoc Physicians India. 40:1992;545-547.
109. Kelly H W, Murphy S. Beta-adrenergic agonists for acute, severe asthma. Ann Pharmacother. 26:1992;81-91.
110. Rebuck A S, Chapman C R, Aboud R, Pare P D, Wolkove N, Vickerson F. Nebulized anticholinergic with sympaticomimetic: treatment of asthma and chronic obstructive airway disease in the emergency room. Am. J. Med. 82:1987;59-64.
111. Aubier M A, Muriano D, Viires N, Lecocguic Y, Palacios S, Pariente R. Increased ventilation caused by improved diaphragmatic efficiency during aminophylline infusion. Am Rev Respir Dis. 127:1983;148-154.
112. Sanders J S, Berman T M, Bartlett M M, Kronenberg R S. Increased hypoxic ventilatory drive due to administration of aminophylline in normal men. Chest. 78:1980;279-282.
113. Lakshminarayan S, Sahn S A, Weil J V. Effect of aminophylline on ventilatory responses in normal men. Am Rev Respir Dis. 117:1978;33-38.
114. Parker J O, Ashekian P B, Di Giorgi S, West R O. Hemodynamic effects of aminophylline in chronic obstructive pulmonary disease. Circulation. 35:1967;366-372.
115. Horiguchi T, Tachikawa S, Kasahara J, Doi M, Shiga M, Miyazaki J. Suppression of airway inflammation by theophylline in adult bronchial asthma. Respiration. 66:1999;124-127.
116. Rabe K F, Dent G. Theophylline and airway inflammation. Clin Exp Allergy. 28:1998;35-41.
117. Skinner M H. Adverse reactions and interactions with theophylline. Drug Saf. 5:1990;275-285.
118. Evans D J, Taylor D A, Zetterström O, Fan Chung K, ÓConnor B, Barnes P J. A comparison of low-dose inhaled budesonide plus theophylline and high dose inhaled budesonide for moderate asthma. N Engl J Med. 337:1997;1412-1418.
119. Pauwels R A. New aspects of the therapeutic potential of theophylline in asthma. J Allergy Clin Immunol. 83:1989;548-553.
120. West Indian Med J. 47:1998;133-152.
121. Carlsen K H. Assessment of the severity of acute asthma in infants and young children. Res Clin Forums. 15:1993;47-52.
122. Geelhoed G C, Landau L I, LeSouëf P N. Predictive value of oxygen saturation in emergency evaluation of asthmatic children. Br Med J. 297:1988;395-396.
123. Mihatsch W, Geelhoed G C, Landau L I, LeSouëf P N. Time course of change in oxygen saturation and peak expiratory flow in children admitted to hospital with acute asthma. Thorax. 45:1990;438-441.
124. Bishop J, Nolan T. Pulse oximetry in acute asthma. Arch Dis Child. 66:1991;724-725.
125. Wennergren G, Engström I, Bjure J. Transcutaneous oxygen and carbon dioxide levels and a clinical symptom scale for monitoring the acute asthma state in infants and young children. Acta Paediatr Scand. 75:1986;465-469.
126. Wennergren G, Holmgren D, Engström I, Sten G F, Bjure J. Using transcutaneous blood gases to evaluate treatment effects on acute asthma in young children. Scand J Clin Lab Invest. 48:1988;41-44.
127. Morris M J, Lane D J. Tidal expiratory flow patterns in airflow obstruction. Thorax. 36:1981;135-142.
128. Lødrup K C, Carlsen K H. The effect of inhaled nebulized racemic epinephrine upon lung function in infants and toddlers with acute bronchiolitis or asthma. Am Rev Respir Dis. 143:1991;A507.
129. Carlsen K H, Lødrup Carlsen K C. Tidal breathing analysis and response to salbutamol in awake young children with and without asthma. Eur Respir J. 7:1994;2154-2159.
130. Lødrup K C, Mowinckel P, Carlsen K H. Lung function measurements in awake compared to sleeping newborn infants. Pediatr Pulmonol. 12:1992;99-104.
131. Lødrup Carlsen K C, Carlsen K H. Lung function in awake healthy infants: the first five days of life. Eur Respir J. 6:1993;1496-1500.
132. Schatz M, Zeiger R S. Treatment of asthma and allergic rhinitis during pregnancy. Ann Allergy. 65:1990;427-429.
133. Collop N A, Harman E M. Pulmonary problems in pregnancy. Compr Ther. 16:1990;17-23.
134. Allergy. 47:1992;1-61.
135. Metzger W J. Indications for allergen immunotherapy during pregnancy. Compr Ther. 16:1990;17-26.
136. Lin R Y, LaFrance J, Sauter D. Hypersensitivity to common indoor aeroallergens in asthmatic patients. Ann Allergy. 71:1993;33-39.
137. Brunekreff B, Grott B, Hoek G. Pets, allergy and respiratory symptoms in children. Int J Epidemiol. 21:1992;338-342.
138. Maeda Y, Akiyama K, Hasegawa M, Hayakawa T, Kaneko F, Ohtomo M, Shida T, Miyamoto T. A study of sensitization and symptoms in adult asthmatics who keep cat and dog. Arerugi. 42:1993;691-698.
139. Ruiz R G, Kemeny D M, Price J F. Higher risk of infantile atopic dermatitis from maternal atopy than from paternal atopy. Clin Exp Allergy. 22:1992;762-766.
140. Hansen L G, Halken S, Høst A, Møller K, Østerballe O. Prediction of allergy from family history and cord blood IgE levels. A follow-up at the age of 5 years. Cord blood IgE. IV. Pediatr Allergy Immunol. 4:1993;34-40.
141. Aalberse R C, Nieuwenhuys E J, Het M, Stapel S O. 'Horoscope effect' not only for seasonal but also for non-seasonal allergens. Clin Exp Allergy. 22:1992;1003-1006.
142. Halken S, Høst A, Husby S, Hansen L G, Østerballe O, Nyboe J. Recurrent wheezing in relation to environmental risk factors in infancy. A prospective study of 276 infants. Allergy. 46:1991;507-514.
143. Cook D G, Strachan D P. Parental smoking, bronchial reactivity and peak flow variability in children. Thorax. 53:1998;295-301.
144. Berge M, Munir A K, Dreborg S. Concentrations of cat (Fel d1), dog (Can f1) and mite (Der f1 and Der p1) allergens in the clothing and school environment of Swedish schoolchildren with and without pets at home. Pediatr Allergy Immunol. 9:1998;25-30.
145. Robinson D M, Egglestone D M, Hill P M, Rea H H, Richards G N, Robinson S M. Effects of a physical conditioning programme on asthmatic patients. N Z Med J. 105:1992;253-256.
146. Cochrane L M, Clark C J. Benefits and problems of a physical training programme for asthmatic patients. Thorax. 45:1990;345-351.
147. Engström I, Fallström K, Karlberg E, Sten G, Bjure J. Psychological and respiratory physiological effects of a physical exercise programme on boys with severe asthma. Acta Paediatr Scand. 80:1991;1058-1065.
148. Mahler D A. Exercise-induced asthma. Med Sci Sports Exerc. 25:1993;554-561.
149. Sontag S J, Schnell T G, Miller T Q, Khandelwal S, O'Connell S, Chejfec G, Greenlee H, Seidel U J, Brand L. Prevalence of oesophagitis in asthmatics. Gut. 33:1992;872-876.
150. Howard P J, Heading R C. Epidemiology of gastro-esophageal reflux disease. World J Surg. 16:1992;288-293.
151. Andze G O, Brandt M L, ST, Vil D, Bensoussan A L, Blanchard H. Diagnosis and treatment of gastroesophageal reflux in 500 children with respiratory symptoms: the value of pH monitoring. J Pediatr Surg. 26:1991;295-299.
152. Pattemore P K, Johnston S L, Bartin P G. Viruses as precipitants of asthma symptoms. I. Epidemiology. Clin Exp Allergy. 22:1992;325-336.
153. Sterk P J. Virus-induced airway hyperresponsiveness in man. Eur Respir J. 6:1993;894-902.
154. Sly P D, Hibbert M E. Childhood asthma following hospitalization with acute viral bronchiolitis in infancy. Pediatr Pulmonol. 7:1989;153-158.
155. Wittig H J, Cranford N J, Glaser J. The relationship between bronchiolitis and childhood asthma: a follow-up study of 100 cases of bronchiolitis in infancy. J Allergy. 30:1959;19-23.
156. Hogg J. Asthma as a bronchiolitis. Am Rev Respir Dis. 13:1992;114-118.
157. Michaud P A, Frappier J Y, Pless I B. La compliance d'adolescents souffrant d'une maladie chronique. Arch Fr Pediatr. 48:1991;329-336.
158. Kotses H, Stout C, Wigal J K, Carlson B, Creer T L, Lewis P. Individualized asthma self-management: a beginning. J Asthma. 28:1991;287-289.